<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Allylestrenol</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Allylestrenol">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Allylestrenol</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Allylestrenol</b>, sold under the brand names <b>Gestanin</b> and <b>Turinal</b> among others, is a progestin medication which is used to treat recurrent and threatened miscarriage and to prevent premature labor in pregnant women.<span class="mw-ref" id="cite_ref-Martindale_6-0"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid7459930_7-0"><a href="#cite_note-pmid7459930-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-:0_8-0"><a href="#cite_note-:0-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> However, except in the case of proven progesterone deficiency, its use for such purposes is no longer recommended.<span class="mw-ref" id="cite_ref-Martindale_6-1"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> It is also used in Japan to treat benign prostatic hyperplasia (BPH) in men.<span class="mw-ref" id="cite_ref-pmid1722627_9-0"><a href="#cite_note-pmid1722627-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid1722628_10-0"><a href="#cite_note-pmid1722628-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid12534901_11-0"><a href="#cite_note-pmid12534901-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> The medication is used alone and is not formulated in combination with an estrogen.<span class="mw-ref" id="cite_ref-Muller1998_12-0"><a href="#cite_note-Muller1998-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> It is taken by mouth.<span class="mw-ref" id="cite_ref-Seth2009_13-0"><a href="#cite_note-Seth2009-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Allylestrenol</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Allylestrenol.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Allylestrenol.svg.png" data-file-width="512" data-file-height="457" data-file-type="drawing" height="179" width="200"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Allylestrenol_molecule_ball.png" tppabs="https://ptable.com/wiki/compounds/I/m/Allylestrenol_molecule_ball.png" data-file-width="2560" data-file-height="1789" data-file-type="bitmap" height="175" width="250"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Gestanin, Gestanon, Perselin, Turinal, others</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>Allyloestrenol; SC-6393; Org AL-25; 3-Deketo-17α-allyl-19-nortestosterone; 17α-Allylestr-4-en-17β-ol; 17α-(Prop-2-en-1-yl)estr-4-en-17β-ol</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">

<ul><li>Used in threatened miscarriage and recurrent pregnancy loss</li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Drug class</th><td>Progestogen; Progestin</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>G03DC01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=G03DC01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=G03DC01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=G03DC01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>"Considerable"<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-0"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-0"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> (and low affinity for <abbr>SHBG</abbr>)<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-0"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>Liver (reduction, hydroxylation, conjugation; CYP3A4)<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-1"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-1"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-SuperCYP_4-0"><a href="#cite_note-SuperCYP-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>• <abbr>17α-Allyl-19-NT</abbr><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-1"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-2"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-2"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>"Several hours" or 10 hours<span class="mw-ref" id="cite_ref-SahaRoy2000_5-0"><a href="#cite_note-SahaRoy2000-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-3"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-3"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (as conjugates)<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-4"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-4"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">(8<i>R</i>,9<i>S</i>,10<i>R</i>,13<i>S</i>,14<i>S</i>,17<i>R</i>)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1<i>H</i>-cyclopenta[<i>a</i>]phenanthren-17-ol</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=432-60-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=432-60-0'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=432-60-0" class="external text external">432-60-0</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/235905  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/235905'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/235905" class="external text external">235905</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB01431  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB01431'" tppabs="https://www.drugbank.ca/drugs/DB01431" class="external text external">DB01431</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.205855.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.205855.html'" tppabs="http://www.chemspider.com/Chemical-Structure.205855.html" class="external text external">205855</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I47VB5DZ8O  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I47VB5DZ8O'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=I47VB5DZ8O" class="external text external">I47VB5DZ8O</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D01374  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D01374'" tppabs="https://www.kegg.jp/entry/D01374" class="external text external">D01374</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31189  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31189'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:31189" class="external text external">CHEBI:31189</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2105618  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2105618'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL2105618" class="external text external">ChEMBL2105618</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID9022574  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID9022574'" tppabs="https://comptox.epa.gov/dashboard/DTXSID9022574" class="external text external">DTXSID9022574</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.006.440  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.006.440'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.006.440" class="external text external">100.006.440</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>21</sub><span>H</span><sub>32</sub><span>O</span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">300.486</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28CC%3DC%29O%29CCC4%3DCCCC%5BC%40H%5D34  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28CC%3DC%29O%29CCC4%3DCCCC%5BC%40H%5D34'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=C%5BC%40%5D12CC%5BC%40H%5D3%5BC%40H%5D%28%5BC%40%40H%5D1CC%5BC%40%5D2%28CC%3DC%29O%29CCC4%3DCCCC%5BC%40H%5D34" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(CC=C)O)CCC4=CCCC[C@H]34</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16-,17+,18+,19-,20-,21-/m0/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:ATXHVCQZZJYMCF-XUDSTZEESA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477248526&page2=Allylestrenol  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477248526&page2=Allylestrenol'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477248526&page2=Allylestrenol" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>Side effects of allylestrenol are few and have not been well-defined, but are assumed to be similar to those of related medications.<span class="mw-ref" id="cite_ref-Borglin1960_14-0"><a href="#cite_note-Borglin1960-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Allylestrenol is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of progestogens like <a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">progesterone</a>.<span class="mw-ref" id="cite_ref-pmid13699366_15-0"><a href="#cite_note-pmid13699366-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> It has no other important hormonal activity.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-2"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Madjerekde_Visser1960_16-0"><a href="#cite_note-Madjerekde_Visser1960-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> The medication is a prodrug of 17α-allyl-19-nortestosterone (3-ketoallylestrenol) in the body.<span class="mw-ref" id="cite_ref-pmid18395441_17-0"><a href="#cite_note-pmid18395441-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-0"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-3"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>Allylestrenol was first described in 1958 and was introduced for medical use by 1961.<span class="mw-ref" id="cite_ref-Publishing2013_19-0"><a href="#cite_note-Publishing2013-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-Field-RichardsSnaith1961_20-0"><a href="#cite_note-Field-RichardsSnaith1961-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-SimpsonWeiner1997_21-0"><a href="#cite_note-SimpsonWeiner1997-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-Juta1962_22-0"><a href="#cite_note-Juta1962-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> It has been marketed widely throughout the world in the past, but today its availability and usage are relatively limited.<span class="mw-ref" id="cite_ref-Micromedex_23-0"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-2"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-0"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-0"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It remains available in a few European countries and in a number of Asian countries.<span class="mw-ref" id="cite_ref-Micromedex_23-1"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-3"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-1"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-1"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc"></div>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Allylestrenol is used in the treatment of recurrent and threatened miscarriage and to prevent premature labor.<span class="mw-ref" id="cite_ref-Martindale_6-4"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-pmid7459930_7-1"><a href="#cite_note-pmid7459930-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> However, except in the case of proven progesterone deficiency, its use for such indications is no longer recommended.<span class="mw-ref" id="cite_ref-Martindale_6-5"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Allylestrenol is one of only a handful of progestogens that has commonly been used for such purposes, the others including progesterone, hydroxyprogesterone caproate, and <a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">dydrogesterone</a>.<span class="mw-ref" id="cite_ref-:0_8-1"><a href="#cite_note-:0-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The medication has also been studied in the treatment of gynecological disorders such as amenorrhea, irregular menstruation, and premenstrual syndrome.<span class="mw-ref" id="cite_ref-Borglin1960_14-1"><a href="#cite_note-Borglin1960-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> Unlike other progestins, allylestrenol has not been used in hormonal contraception or in menopausal hormone therapy. In one study, it was found to be inadequate for endometrial transformation in women in combination with estradiol valerate.<span class="mw-ref" id="cite_ref-pmid3609436_26-0"><a href="#cite_note-pmid3609436-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> On the other hand, allylestrenol was found to be effective in the treatment of hot flashes in postmenopausal women.<span class="mw-ref" id="cite_ref-pmid1473164_27-0"><a href="#cite_note-pmid1473164-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Allylestrenol has been commonly used in Japan at high dosages, typically 50<span>&nbsp;</span>mg/day but as much as 100<span>&nbsp;</span>mg/day, to treat BPH in men.<span class="mw-ref" id="cite_ref-pmid12534901_11-1"><a href="#cite_note-pmid12534901-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-pmid6203385_28-0"><a href="#cite_note-pmid6203385-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span><span class="mw-ref" id="cite_ref-pmid2425610_29-0"><a href="#cite_note-pmid2425610-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span><span class="mw-ref" id="cite_ref-pmid2425611_30-0"><a href="#cite_note-pmid2425611-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span><span class="mw-ref" id="cite_ref-pmid2426932_31-0"><a href="#cite_note-pmid2426932-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid2426933_32-0"><a href="#cite_note-pmid2426933-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid2435122_33-0"><a href="#cite_note-pmid2435122-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693037_34-0"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693038_35-0"><a href="#cite_note-pmid1693038-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span><span class="mw-ref" id="cite_ref-pmid1722627_9-1"><a href="#cite_note-pmid1722627-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-pmid1722628_10-1"><a href="#cite_note-pmid1722628-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-pmid1384295_36-0"><a href="#cite_note-pmid1384295-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span><span class="mw-ref" id="cite_ref-pmid7689782_37-0"><a href="#cite_note-pmid7689782-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span><span class="mw-ref" id="cite_ref-pmid7513937_38-0"><a href="#cite_note-pmid7513937-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span><span class="mw-ref" id="cite_ref-pmid7541089_39-0"><a href="#cite_note-pmid7541089-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-pmid9781436_40-0"><a href="#cite_note-pmid9781436-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span><span class="mw-ref" id="cite_ref-pmid11107528_41-0"><a href="#cite_note-pmid11107528-41" style="counter-reset: mw-Ref 41;"><span class="mw-reflink-text">[41]</span></a></span><span class="mw-ref" id="cite_ref-pmid12094708_42-0"><a href="#cite_note-pmid12094708-42" style="counter-reset: mw-Ref 42;"><span class="mw-reflink-text">[42]</span></a></span><span class="mw-ref" id="cite_ref-pmid16910584_43-0"><a href="#cite_note-pmid16910584-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span> Related medications that have similarly been used to treat BPH, particularly in Japan, include chlormadinone acetate, gestonorone caproate, and oxendolone.<span class="mw-ref" id="cite_ref-pmid2435122_33-1"><a href="#cite_note-pmid2435122-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span><span class="mw-ref" id="cite_ref-pmid7513937_38-1"><a href="#cite_note-pmid7513937-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Allylestrenol has also been studied in the treatment of prostate cancer in Japan.<span class="mw-ref" id="cite_ref-pmid6281750_44-0"><a href="#cite_note-pmid6281750-44" style="counter-reset: mw-Ref 44;"><span class="mw-reflink-text">[44]</span></a></span><span class="mw-ref" id="cite_ref-pmid6203385_28-1"><a href="#cite_note-pmid6203385-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> The medication has been studied as a puberty blocker in the treatment of precocious puberty as well.<span class="mw-ref" id="cite_ref-pmid5057420_45-0"><a href="#cite_note-pmid5057420-45" style="counter-reset: mw-Ref 45;"><span class="mw-reflink-text">[45]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Available_forms">Available forms</h3></summary>
    
<p>Allylestrenol is available in the form of 5<span>&nbsp;</span>mg oral tablets.<span class="mw-ref" id="cite_ref-Muller1998_12-1"><a href="#cite_note-Muller1998-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-Tripathi2013_46-0"><a href="#cite_note-Tripathi2013-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-SatoskarRege1973_47-0"><a href="#cite_note-SatoskarRege1973-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> It is typically used at a dosage of 5 to 40<span>&nbsp;</span>mg/day.<span class="mw-ref" id="cite_ref-Tripathi2013_46-1"><a href="#cite_note-Tripathi2013-46" style="counter-reset: mw-Ref 46;"><span class="mw-reflink-text">[46]</span></a></span><span class="mw-ref" id="cite_ref-SatoskarRege1973_47-1"><a href="#cite_note-SatoskarRege1973-47" style="counter-reset: mw-Ref 47;"><span class="mw-reflink-text">[47]</span></a></span> In Japan, a 25<span>&nbsp;</span>mg allylestrenol oral tablet, under the brand name Perselin, is marketed for the treatment of BPH.<span class="mw-ref" id="cite_ref-pmid7689782_37-1"><a href="#cite_note-pmid7689782-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side_effects">Side effects</h2></summary>
    


<p>Side effects of allylestrenol are few and have not been well-defined, but are assumed to be similar to those of related medications (i.e., other progestins).<span class="mw-ref" id="cite_ref-Borglin1960_14-2"><a href="#cite_note-Borglin1960-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> When used at high dosages in the treatment of BPH in men, allylestrenol can cause symptoms of hypogonadism and sexual dysfunction.<span class="mw-ref" id="cite_ref-pmid2426932_31-1"><a href="#cite_note-pmid2426932-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693037_34-1"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693038_35-1"><a href="#cite_note-pmid1693038-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> The medication indeloxazine may be able to counteract allylestrenol-associated sexual dysfunction.<span class="mw-ref" id="cite_ref-pmid7541089_39-1"><a href="#cite_note-pmid7541089-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> Allylestrenol has no androgenic or other off-target hormonal side effects.<span class="mw-ref" id="cite_ref-pmid2426932_31-2"><a href="#cite_note-pmid2426932-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-4"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Madjerekde_Visser1960_16-1"><a href="#cite_note-Madjerekde_Visser1960-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacodynamics">Pharmacodynamics</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:227px"><img src="../I/m/17α-Allyl-19-nortestosterone.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/17%CE%B1-Allyl-19-nortestosterone.svg.png" data-file-width="1125" data-file-height="885" data-file-type="drawing" height="177" width="225"><div class="thumbcaption" style="text-align: left">17α-Allyl-19-nortestosterone, also known as 3-ketoallylestrenol, the active form of allylestrenol.</div></div></div>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Progestogenic_and_off-target_activities">Progestogenic and off-target activities</h4></summary>
    
<p>Allylestrenol is a progestogen, or an agonist of the progesterone receptor (PR).<span class="mw-ref" id="cite_ref-pmid13699366_15-1"><a href="#cite_note-pmid13699366-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> It is lacking the keto group at the C3 position (part of the important <i>3-keto-4-ene</i> structure) that is common in progestogens and is considered to be necessary for activity, and in relation to this, is thought to be a prodrug of 17α-allyl-19-nortestosterone (3-ketoallylestrenol).<span class="mw-ref" id="cite_ref-pmid18395441_17-1"><a href="#cite_note-pmid18395441-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-1"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span><span class="mw-ref" id="cite_ref-pmid7065053_48-0"><a href="#cite_note-pmid7065053-48" style="counter-reset: mw-Ref 48;"><span class="mw-reflink-text">[48]</span></a></span> Allylestrenol is a far less potent progestogen than many other 19-nortestosterone derivatives.<span class="mw-ref" id="cite_ref-pmid13699366_15-2"><a href="#cite_note-pmid13699366-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span> The effective ovulation-inhibiting or contraceptive dosage of allylestrenol in women has been studied, albeit limitedly.<span class="mw-ref" id="cite_ref-pmid22078182_49-0"><a href="#cite_note-pmid22078182-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span> At 20<span>&nbsp;</span>mg/day allylestrenol, ovulation occurred in 50% of 6<span>&nbsp;</span>cycles, and at 25<span>&nbsp;</span>mg/day, ovulation occurred in 0% of 3<span>&nbsp;</span>cycles.<span class="mw-ref" id="cite_ref-pmid22078182_49-1"><a href="#cite_note-pmid22078182-49" style="counter-reset: mw-Ref 49;"><span class="mw-reflink-text">[49]</span></a></span><span class="mw-ref" id="cite_ref-Pincus2013_50-0"><a href="#cite_note-Pincus2013-50" style="counter-reset: mw-Ref 50;"><span class="mw-reflink-text">[50]</span></a></span> The total endometrial transformation dosage of allylestrenol in women across the cycle is 150 to 250<span>&nbsp;</span>mg.<span class="mw-ref" id="cite_ref-LeidenbergerStrowitzki2009_51-0"><a href="#cite_note-LeidenbergerStrowitzki2009-51" style="counter-reset: mw-Ref 51;"><span class="mw-reflink-text">[51]</span></a></span> Unlike virtually all other 19-nortestosterone derivatives, allylestrenol is reported to be a pure progestogen and hence to be devoid of androgenic, estrogenic, and glucocorticoid activity.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-5"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Madjerekde_Visser1960_16-2"><a href="#cite_note-Madjerekde_Visser1960-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span> As such, it appears to have properties more similar to those of natural progesterone.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-6"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Madjerekde_Visser1960_16-3"><a href="#cite_note-Madjerekde_Visser1960-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>

<p>The binding and activity profiles of allylestrenol and its major active metabolite at steroid hormone receptors and related proteins have been studied.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-7"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-pmid18395441_17-2"><a href="#cite_note-pmid18395441-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> Allylestrenol has less than 0.2% of the affinity of ORG-2058 and less than 2% of the affinity of progesterone for the PR.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-8"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Similarly, it has less than 0.2% of the affinity of testosterone for the androgen receptor (AR), less than 0.2% of the affinity of estradiol for the estrogen receptor (ER), less than 0.2% of the affinity of <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone">dexamethasone</a> for the glucocorticoid receptor (GR), and 0.9% of the affinity of testosterone for sex hormone-binding globulin (SHBG).<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-9"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Conversely, its metabolite 17α-allyl-19-nortestosterone has 24% of the affinity of ORG-2058 and 186% of the affinity of progesterone for the PR, 4.5% of the affinity of testosterone for the AR, 9.8% of the affinity of dexamethasone for the GR, and 2.8% of the affinity of testosterone for SHBG, while it similarly has less than 0.2% of the affinity of estradiol for the ER.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-10"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The affinity of 17α-allyl-19-nortestosterone for the AR was less than that of <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a> and <a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">medroxyprogesterone acetate</a> and its affinity for SHBG was much lower than that of norethisterone.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-11"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> These findings may help to explain the absence of teratogenic effects of allylestrenol on the external genitalia of female and male rat fetuses.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-12"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<table class="wikitable mw-collapsible mw-collapsed" style="text-align:left; margin-left:auto; margin-right:auto; border:none;">
<caption class="nowrap">Relative affinities (%) of allylestrenol and metabolites</caption>
<tbody><tr>
<th>Compound</th><th><abbr>PR</abbr></th><th><abbr>AR</abbr></th><th><abbr>ER</abbr></th><th><abbr>GR</abbr></th><th><abbr>MR</abbr></th><th><abbr>SHBG</abbr></th><th><abbr>CBG</abbr></th></tr>
<tr>
<td>Allylestrenol</td><td>0</td><td>0</td><td>0</td><td>0</td><td>?</td><td>1</td><td>?</td></tr>
<tr>
<td><abbr>17α-Allyl-19-NT</abbr></td><td>186</td><td>5</td><td>0</td><td>10</td><td>?</td><td>3</td><td>?</td></tr>
<tr class="sortbottom">
<td colspan="8" style="width: 1px; background-color:#eaecf0; text-align: center;"><b>Notes:</b> Values are percentages (%). Reference ligands (100%) were <abbr>P4</abbr> for the <abbr>PR</abbr>, <abbr>T</abbr> for the <abbr>AR</abbr>, <abbr>E2</abbr> for the <abbr>ER</abbr>, <a href="Dexamethasone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dexamethasone" title="Dexamethasone"><abbr>DEXA</abbr></a> for the <abbr>GR</abbr>, <a href="Aldosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Aldosterone" title="Aldosterone">aldosterone</a> for the <abbr>MR</abbr>, <abbr>T</abbr> for <abbr>SHBG</abbr>, and cortisol for <abbr>CBG</abbr>. <b>Sources:</b> <span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-13"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></td></tr>
</tbody></table>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Antigonadotropic_effects">Antigonadotropic effects</h4></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Testosterone_levels_with_50_mg_per_day_allylestrenol_or_50_mg_per_day_chlormadinone_acetate_over_12_weeks_in_men_with_benign_prostatic_hyperplasia.png" tppabs="https://ptable.com/wiki/compounds/I/m/Testosterone_levels_with_50_mg_per_day_allylestrenol_or_50_mg_per_day_chlormadinone_acetate_over_12_weeks_in_men_with_benign_prostatic_hyperplasia.png" data-file-width="1275" data-file-height="1150" data-file-type="bitmap" height="271" width="300"><div class="thumbcaption" style="text-align: left"><a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">Testosterone</a> levels with 50 mg/day allylestrenol or 50 mg/day chlormadinone acetate orally over 12 weeks in men with benign prostatic hyperplasia.<span class="mw-ref" id="cite_ref-pmid1693037_34-2"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span></div></div></div>

<p>Similarly to other progestogens, allylestrenol has potent antigonadotropic effects.<span class="mw-ref" id="cite_ref-pmid9268084_52-0"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid9268084_52-1"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> It is able to considerably decrease circulating concentrations of <a href="Luteinizing_hormone.htm" tppabs="https://ptable.com/wiki/compounds/A/Luteinizing_hormone" title="Luteinizing hormone">luteinizing hormone</a>, <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>, and <a href="Dihydrotestosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dihydrotestosterone" title="Dihydrotestosterone">dihydrotestosterone</a> in men.<span class="mw-ref" id="cite_ref-pmid2426933_32-1"><a href="#cite_note-pmid2426933-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693037_34-3"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid7541089_39-2"><a href="#cite_note-pmid7541089-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span><span class="mw-ref" id="cite_ref-pmid9781436_40-1"><a href="#cite_note-pmid9781436-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> At a dosage of 50<span>&nbsp;</span>mg/day, allylestrenol has been found to suppress circulating testosterone levels by 78% in men with BPH.<span class="mw-ref" id="cite_ref-pmid9268084_52-2"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> This is about the maximum that progestogens are known to be able to suppress testosterone levels in men.<span class="mw-ref" id="cite_ref-pmid7000222_53-0"><a href="#cite_note-pmid7000222-53" style="counter-reset: mw-Ref 53;"><span class="mw-reflink-text">[53]</span></a></span><span class="mw-ref" id="cite_ref-pmid6237116_54-0"><a href="#cite_note-pmid6237116-54" style="counter-reset: mw-Ref 54;"><span class="mw-reflink-text">[54]</span></a></span><span class="mw-ref" id="cite_ref-pmid694436_55-0"><a href="#cite_note-pmid694436-55" style="counter-reset: mw-Ref 55;"><span class="mw-reflink-text">[55]</span></a></span> In accordance, the reduction of testosterone and luteinizing hormone levels with allylestrenol in men has been found in a study to be equivalent to that of chlormadinone acetate and oxendolone.<span class="mw-ref" id="cite_ref-pmid2435122_33-2"><a href="#cite_note-pmid2435122-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span> However, another study found a significantly lower decrease in testosterone levels with 50<span>&nbsp;</span>mg/day allylestrenol relative to 50<span>&nbsp;</span>mg/day chlormadinone acetate of about 49–52% versus 76–85%, respectively.<span class="mw-ref" id="cite_ref-pmid1693037_34-4"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> Animal research suggests that allylestrenol produces its beneficial effects in BPH via its antigonadotropic effects and consequent suppression of androgen levels and inhibition of prostate gland growth, similarly to other progestins.<span class="mw-ref" id="cite_ref-pmid9268084_52-3"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> Some studies have found that allylestrenol is less effective for BPH than chlormadinone acetate but also produces fewer side effects and sexual dysfunction.<span class="mw-ref" id="cite_ref-pmid2426932_31-3"><a href="#cite_note-pmid2426932-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693037_34-5"><a href="#cite_note-pmid1693037-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span><span class="mw-ref" id="cite_ref-pmid1693038_35-2"><a href="#cite_note-pmid1693038-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> Allylestrenol therapy for BPH is associated with a significant decrease in prostate-specific antigen levels, which may mask the detection of prostate cancer.<span class="mw-ref" id="cite_ref-pmid9268084_52-4"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span><span class="mw-ref" id="cite_ref-pmid16910584_43-1"><a href="#cite_note-pmid16910584-43" style="counter-reset: mw-Ref 43;"><span class="mw-reflink-text">[43]</span></a></span></p>


</details>
<details data-level="4" open="">
    <summary class="section-heading"><h4 id="Other_activities">Other activities</h4></summary>
    
<p>Allylestrenol is not a significant 5α-reductase inhibitor.<span class="mw-ref" id="cite_ref-pmid9268084_52-5"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In one study, it showed about 80,000-fold lower potency for inhibition of 5α-reductase <i>in vitro</i> than the established 5α-reductase inhibitor epristeride (<abbr>IC<sub>50</sub></abbr> = 11.3<span>&nbsp;</span>nM for epristeride and 890<span>&nbsp;</span>μM for allylestrenol).<span class="mw-ref" id="cite_ref-pmid9268084_52-6"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> In another study, there was 70% inhibition of 5α-reductase by allylestrenol at a concentration of 60<span>&nbsp;</span>μM.<span class="mw-ref" id="cite_ref-pmid9268084_52-7"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span> This difference may have been due to different experimental conditions, but is still much lower than epristeride.<span class="mw-ref" id="cite_ref-pmid9268084_52-8"><a href="#cite_note-pmid9268084-52" style="counter-reset: mw-Ref 52;"><span class="mw-reflink-text">[52]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Following oral administration, peak levels of allylestrenol occur after 2 to 4<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-5"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-5"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> The medication shows considerable plasma protein binding.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-6"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-6"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It has relatively low affinity for SHBG, much lower than that of norethisterone.<span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-14"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> Allylestrenol is metabolized in the liver, via reduction, hydroxylation, and conjugation.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-7"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-7"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is known to be a substrate of CYP3A4.<span class="mw-ref" id="cite_ref-SuperCYP_4-1"><a href="#cite_note-SuperCYP-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is thought to be a prodrug of 17α-allyl-19-nortestosterone (3-ketoallylestrenol), which, in accordance, is a known active metabolite of allylestrenol.<span class="mw-ref" id="cite_ref-pmid18395441_17-3"><a href="#cite_note-pmid18395441-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-2"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The biological half-life of allylestrenol has been reported to be "several hours" or, presumably in its active form, reportedly about 10<span>&nbsp;</span>hours.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-8"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-8"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span><span class="mw-ref" id="cite_ref-SahaRoy2000_5-1"><a href="#cite_note-SahaRoy2000-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> In the blood, unchanged allylestrenol accounted for 15 to 40% of radioactivity, an unconjugated metabolite accounted for 4 to 10% of radioactivity, and the rest of the radioactivity corresponded to conjugated metabolites.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-9"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-9"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> Allylestrenol is eliminated mainly in urine, 44% by 24<span>&nbsp;</span>hours and 67% within 4<span>&nbsp;</span>days.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-10"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-10"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> It is excreted almost completely as conjugates, with 75% of these being sulfate conjugates and 24% being glucuronide conjugates.<span class="mw-ref" id="cite_ref-BengtssonTausk1972_1-11"><a href="#cite_note-BengtssonTausk1972-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span><span class="mw-ref" id="cite_ref-Thijssen1967_2-11"><a href="#cite_note-Thijssen1967-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemistry">Chemistry</h2></summary>
    


<p>Allylestrenol, also known as 3-deketo-17α-allyl-19-nortestosterone or as 17α-allylestr-4-en-17β-ol, is a synthetic estrane steroid and a derivative of <a href="Testosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testosterone" title="Testosterone">testosterone</a>.<span class="mw-ref" id="cite_ref-Elks2014_56-0"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> It is a member of the estrane subgroup of the <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/19-nortestosterone" title="19-nortestosterone" class="mw-redirect">19-nortestosterone</a> family of progestins,<span class="mw-ref" id="cite_ref-MVJain2017_57-0"><a href="#cite_note-MVJain2017-57" style="counter-reset: mw-Ref 57;"><span class="mw-reflink-text">[57]</span></a></span> but unlike most other 19-nortestosterone progestins, is not a derivative of <a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">norethisterone</a> (17α-ethynyl-19-nortestosterone).<span class="mw-ref" id="cite_ref-Aronson2009_58-0"><a href="#cite_note-Aronson2009-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-15"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-3"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> This is because it possesses an allyl group at the C17α position rather than the usual ethynyl group.<span class="mw-ref" id="cite_ref-Aronson2009_58-1"><a href="#cite_note-Aronson2009-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-16"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-4"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> As such, along with altrenogest (17α-allyl-19-nor-δ<sup>9,11</sup>-testosterone), allylestrenol is a derivative of 17α-allyltestosterone rather than of <a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/17%CE%B1-ethynyltestosterone" title="17α-ethynyltestosterone" class="mw-redirect">17α-ethynyltestosterone</a>.<span class="mw-ref" id="cite_ref-Aronson2009_58-2"><a href="#cite_note-Aronson2009-58" style="counter-reset: mw-Ref 58;"><span class="mw-reflink-text">[58]</span></a></span><span class="mw-ref" id="cite_ref-BerginkLoonen1985_3-17"><a href="#cite_note-BerginkLoonen1985-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Zeelen1990_18-5"><a href="#cite_note-Zeelen1990-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span></p>

<p>Allylestrenol is also unique among most 19-nortestosterone progestins in that it lacks the ketone at the C3 position.<span class="mw-ref" id="cite_ref-Elks2014_56-1"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> It shares this property with lynestrenol (17α-ethynylestr-4-en-17β-ol), <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">desogestrel</a> (11-methylene-17α-ethynyl-18-methylestr-4-en-17β-ol), and the anabolic–androgenic steroid (AAS) <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">ethylestrenol</a> (17α-ethylestr-4-en-17β-ol).<span class="mw-ref" id="cite_ref-Elks2014_56-2"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span> Allylestrenol is the C17α allyl and C3 deketo derivative of the AAS <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> (19-nortestosterone), as well as the C17α allyl and C3 deketo analogue of the AAS normethandrone (17α-methyl-19-nortestosterone) and norethandrolone (17α-methyl-19-nortestosterone).<span class="mw-ref" id="cite_ref-Elks2014_56-3"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Synthesis">Synthesis</h3></summary>
    
<p>Chemical syntheses of allylestrenol have been published.<span class="mw-ref" id="cite_ref-Elks2014_56-4"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-Publishing2013_19-1"><a href="#cite_note-Publishing2013-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span><span class="mw-ref" id="cite_ref-GunnetDixon2000_59-0"><a href="#cite_note-GunnetDixon2000-59" style="counter-reset: mw-Ref 59;"><span class="mw-reflink-text">[59]</span></a></span><span class="mw-ref" id="cite_ref-Springer2013_60-0"><a href="#cite_note-Springer2013-60" style="counter-reset: mw-Ref 60;"><span class="mw-reflink-text">[60]</span></a></span><span class="mw-ref" id="cite_ref-DeWinterSiegman1959_61-0"><a href="#cite_note-DeWinterSiegman1959-61" style="counter-reset: mw-Ref 61;"><span class="mw-reflink-text">[61]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Allylestrenol was patented in 1958<span class="mw-ref" id="cite_ref-Publishing2013_19-2"><a href="#cite_note-Publishing2013-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> and has been marketed for medical use since 1961.<span class="mw-ref" id="cite_ref-Field-RichardsSnaith1961_20-1"><a href="#cite_note-Field-RichardsSnaith1961-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span><span class="mw-ref" id="cite_ref-SimpsonWeiner1997_21-1"><a href="#cite_note-SimpsonWeiner1997-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span><span class="mw-ref" id="cite_ref-Juta1962_22-1"><a href="#cite_note-Juta1962-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> It was developed by Organon Laboratories.<span class="mw-ref" id="cite_ref-Juta1962_22-2"><a href="#cite_note-Juta1962-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-SimpsonWeiner1997_21-2"><a href="#cite_note-SimpsonWeiner1997-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Society_and_culture">Society and culture</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Generic_names">Generic names</h3></summary>
    
<p><i>Allylestrenol</i> is the generic name of the drug and its <abbr>INN</abbr>, <abbr>BAN</abbr>, and <abbr>JAN</abbr>, while <i>allylestrénol</i> is its <abbr>DCF</abbr> and <i>allilestrenolo</i> is its <abbr>DCIT</abbr>.<span class="mw-ref" id="cite_ref-Elks2014_56-5"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-2"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-MortonHall2012_62-0"><a href="#cite_note-MortonHall2012-62" style="counter-reset: mw-Ref 62;"><span class="mw-reflink-text">[62]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-2"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> The <abbr>BAN</abbr> was originally <i>allyloestrenol</i>, but it was eventually changed.<span class="mw-ref" id="cite_ref-Elks2014_56-6"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-3"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-3"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> The medication is also known by its developmental code name <i>SC-6393</i>.<span class="mw-ref" id="cite_ref-Elks2014_56-7"><a href="#cite_note-Elks2014-56" style="counter-reset: mw-Ref 56;"><span class="mw-reflink-text">[56]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-4"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-4"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Brand_names">Brand names</h3></summary>
    
<p>The major brand names of allylestrenol include Gestanin, Gestanon, Perselin, and Turinal.<span class="mw-ref" id="cite_ref-Micromedex_23-2"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-6"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-5"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-5"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Publishing2013_19-3"><a href="#cite_note-Publishing2013-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> It has also been marketed under a variety of other brand names, including Alese, Alilestrenol, Allynol, Allytry, Alynol, Anin, Arandal, Astanol, Cobarenol, Crestanon, Elmolan, Fetugard, Foegard, Fulterm, Gestanin, Gestanin, Gestanol, Gestanyn, Gestin, Geston, Gestormone, Gestrenol, Gravida, Gravidin, Gravinol, Gravion, Gravynon, Gynerol, Gynonys, Iugr, Lestron, Loestrol, Maintane, Meieston, Moresafe, Nidagest, Orageston, Pelias, Preabor, Pregnolin, Pregtenol, Pregular, Prelab, Premaston, Prenolin, Prestrenol, Profar, Progeston, Protanon, and Shegest.<span class="mw-ref" id="cite_ref-Micromedex_23-3"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-7"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-6"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-6"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span><span class="mw-ref" id="cite_ref-Publishing2013_19-4"><a href="#cite_note-Publishing2013-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Availability">Availability</h3></summary>
    
<div class="thumb tright"><div class="thumbinner" style="width:302px"><img src="../I/m/Allylestrenol_availability.png" tppabs="https://ptable.com/wiki/compounds/I/m/Allylestrenol_availability.png" data-file-width="4000" data-file-height="2155" data-file-type="bitmap" height="162" width="300"><div class="thumbcaption" style="text-align: left">Availability of allylestrenol in countries throughout the world as of December 2017. Blue is currently marketed, green is formerly marketed.</div></div></div><p>

Allylestrenol has been marketed widely throughout the world, including in Europe, Southern, Eastern, and Southeastern Asia, Africa, Oceania, and Latin America.<span class="mw-ref" id="cite_ref-Micromedex_23-4"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-8"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-7"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-7"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> However, although it has been widely marketed in the past, the availability of allylestrenol is relatively limited today.<span class="mw-ref" id="cite_ref-Micromedex_23-5"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-9"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-8"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-8"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It appears to still be available in Bangladesh, the <a href="Czech_Republic.htm" tppabs="https://ptable.com/wiki/compounds/A/Czech_Republic" title="Czech Republic">Czech Republic</a>, Egypt, Hong Kong, India, Indonesia, Japan, Lithuania, Malaysia, the Philippines, Russia, Singapore, and Taiwan.<span class="mw-ref" id="cite_ref-Micromedex_23-6"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-10"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-9"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-9"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> Previously, allylestrenol has also been available in Australia, Austria, Belgium, Brazil, Germany, Greece, Hungary, Italy, Luxembourg, Mexico, Poland, South Africa, Spain, Sweden, Switzerland, Turkey, Ukraine, the United Kingdom, and Yugoslavia (now Serbia and Montenegro).<span class="mw-ref" id="cite_ref-Micromedex_23-7"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-11"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-10"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-10"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> However, it seems to have been discontinued in these countries.<span class="mw-ref" id="cite_ref-Micromedex_23-8"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-12"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-11"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-11"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> It does not seem to have been marketed in the United States or Canada.<span class="mw-ref" id="cite_ref-Micromedex_23-9"><a href="#cite_note-Micromedex-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span><span class="mw-ref" id="cite_ref-Martindale_6-13"><a href="#cite_note-Martindale-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span><span class="mw-ref" id="cite_ref-Drugs.com_24-12"><a href="#cite_note-Drugs.com-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span><span class="mw-ref" id="cite_ref-IndexNominum2000_25-12"><a href="#cite_note-IndexNominum2000-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p><div style="clear:both;"></div>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-BengtssonTausk1972-1"> <span id="mw-reference-text-cite_note-BengtssonTausk1972-1" class="mw-reference-text"><cite id="CITEREFBengtssonTausk1972" class="citation book cs1">Bengtsson LP, Tausk M (September 1972). <a href="javascript:if(confirm('https://books.google.com/books?id=Nv5sAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=Nv5sAAAAMAAJ'" tppabs="https://books.google.com/books?id=Nv5sAAAAMAAJ" class="external text external"><i>Pharmacology of the endocrine system and related drugs: progesterone, progestational drugs and antifertility agents</i></a>. Pergamon Press. pp.<span>&nbsp;</span>235–237.</cite></span></li><li id="cite_note-Thijssen1967-2"> <span id="mw-reference-text-cite_note-Thijssen1967-2" class="mw-reference-text"><cite id="CITEREFThijssen1967" class="citation thesis cs1">Thijssen JH (1967). <i>Het metabolisme van progestatieve stoffen</i> (Thesis). Rijksuniversiteit te Utrecht.</cite></span></li><li id="cite_note-BerginkLoonen1985-3"> <span id="mw-reference-text-cite_note-BerginkLoonen1985-3" class="mw-reference-text"><cite id="CITEREFBerginkLoonenKloosterboer1985" class="citation journal cs1">Bergink EW, Loonen PB, Kloosterboer HJ (August 1985). "Receptor binding of allylestrenol, a progestagen of the 19-nortestosterone series without androgenic properties". <i>Journal of Steroid Biochemistry</i>. <b>23</b> (2): 165–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0022-4731%2885%2990232-8  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0022-4731%2885%2990232-8'" tppabs="https://doi.org/10.1016%2F0022-4731%2885%2990232-8" class="external text external">10.1016/0022-4731(85)90232-8</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3928974  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3928974'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3928974" class="external text external">3928974</a>.</cite></span></li><li id="cite_note-SuperCYP-4"> <span id="mw-reference-text-cite_note-SuperCYP-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://bioinformatics.charite.de/supercyp/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://bioinformatics.charite.de/supercyp/'" tppabs="http://bioinformatics.charite.de/supercyp/" class="external text external">"SuperCYP"</a>.</cite></span></li><li id="cite_note-SahaRoy2000-5"> <span id="mw-reference-text-cite_note-SahaRoy2000-5" class="mw-reference-text"><cite id="CITEREFSahaRoyKakali2000" class="citation journal cs1">Saha A, Roy K, Kakali DE (2000). "Effects of Allylestrenol on Blood Lipids in Relation to its Biological Activity". <i>Indian Journal of Pharmaceutical Sciences</i>. <b>62</b> (2): 115.</cite></span></li><li id="cite_note-Martindale-6"> <span id="mw-reference-text-cite_note-Martindale-6" class="mw-reference-text"><cite id="CITEREFSweetman,_Sean_C.2009" class="citation book cs1">Sweetman, Sean C., ed. (2009). <a href="javascript:if(confirm('https://www.medicinescomplete.com/mc/martindale/2009/9023-n.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicinescomplete.com/mc/martindale/2009/9023-n.htm'" tppabs="https://www.medicinescomplete.com/mc/martindale/2009/9023-n.htm" class="external text external">"Sex hormones and their modulators"</a>. <i>Martindale: The Complete Drug Reference</i> (36th ed.). London: Pharmaceutical Press. p.<span>&nbsp;</span>2082. ISBN<span>&nbsp;</span><bdi>978-0-85369-840-1</bdi>.</cite></span></li><li id="cite_note-pmid7459930-7"> <span id="mw-reference-text-cite_note-pmid7459930-7" class="mw-reference-text"><cite id="CITEREFCortés-PrietoBoschRocha1980" class="citation journal cs1">Cortés-Prieto J, Bosch AO, Rocha JA (1980). "Allylestrenol: three years of experience with Gestanon in threatened abortion and premature labor". <i>Clinical Therapeutics</i>. <b>3</b> (3): 200–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7459930  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7459930'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7459930" class="external text external">7459930</a>.</cite></span></li><li id="cite_note-:0-8"> <span id="mw-reference-text-cite_note-:0-8" class="mw-reference-text"><cite id="CITEREFHaasHathawayRamsey2019" class="citation journal cs1">Haas, David M.; Hathaway, Taylor J.; Ramsey, Patrick S. (20 November 2019). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238" class="external text external">"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2019</b> (11). doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD003511.pub5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD003511.pub5'" tppabs="https://doi.org/10.1002%2F14651858.CD003511.pub5" class="external text external">10.1002/14651858.CD003511.pub5</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/1469-493X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/1469-493X'" tppabs="https://www.worldcat.org/issn/1469-493X" class="external text external">1469-493X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953238" class="external text external">6953238</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31745982  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31745982'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31745982" class="external text external">31745982</a>.</cite></span></li><li id="cite_note-pmid1722627-9"> <span id="mw-reference-text-cite_note-pmid1722627-9" class="mw-reference-text"><cite id="CITEREFKanimotoOkada1991" class="citation journal cs1">Kanimoto Y, Okada K (November 1991). "[Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>37</b> (11): 1423–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1722627  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1722627'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1722627" class="external text external">1722627</a>.</cite></span></li><li id="cite_note-pmid1722628-10"> <span id="mw-reference-text-cite_note-pmid1722628-10" class="mw-reference-text"><cite id="CITEREFUmeda1991" class="citation journal cs1">Umeda K (November 1991). "[Clinical results and problems of anti-androgen therapy of benign prostatic hypertrophy]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>37</b> (11): 1429–33. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1722628  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1722628'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1722628" class="external text external">1722628</a>.</cite></span></li><li id="cite_note-pmid12534901-11"> <span id="mw-reference-text-cite_note-pmid12534901-11" class="mw-reference-text"><cite id="CITEREFIshizukaNishizawaHiraoOhshima2002" class="citation journal cs1">Ishizuka O, Nishizawa O, Hirao Y, Ohshima S (November 2002). "Evidence-based meta-analysis of pharmacotherapy for benign prostatic hypertrophy". <i>International Journal of Urology</i>. <b>9</b> (11): 607–12. doi:<a href="javascript:if(confirm('https://doi.org/10.1046%2Fj.1442-2042.2002.00539.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1046%2Fj.1442-2042.2002.00539.x'" tppabs="https://doi.org/10.1046%2Fj.1442-2042.2002.00539.x" class="external text external">10.1046/j.1442-2042.2002.00539.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12534901  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12534901'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12534901" class="external text external">12534901</a>.</cite></span></li><li id="cite_note-Muller1998-12"> <span id="mw-reference-text-cite_note-Muller1998-12" class="mw-reference-text"><cite id="CITEREFMuller1998" class="citation book cs1">Muller (19 June 1998). <a href="javascript:if(confirm('https://books.google.com/books?id=2HBPHmclMWIC&pg=PA545  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=2HBPHmclMWIC&pg=PA545'" tppabs="https://books.google.com/books?id=2HBPHmclMWIC&pg=PA545" class="external text external"><i>European Drug Index: European Drug Registrations, Fourth Edition</i></a>. CRC Press. pp.<span>&nbsp;</span>545–. ISBN<span>&nbsp;</span><bdi>978-3-7692-2114-5</bdi>.</cite></span></li><li id="cite_note-Seth2009-13"> <span id="mw-reference-text-cite_note-Seth2009-13" class="mw-reference-text"><cite id="CITEREFSeth2009" class="citation book cs1">Seth (18 November 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=51ozlZRBvQwC&pg=RA1-PA71  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=51ozlZRBvQwC&pg=RA1-PA71'" tppabs="https://books.google.com/books?id=51ozlZRBvQwC&pg=RA1-PA71" class="external text external"><i>Textbook Of Pharmacology</i></a>. Elsevier India. pp.<span>&nbsp;</span>1–. ISBN<span>&nbsp;</span><bdi>978-81-312-1158-8</bdi>.</cite></span></li><li id="cite_note-Borglin1960-14"> <span id="mw-reference-text-cite_note-Borglin1960-14" class="mw-reference-text"><cite id="CITEREFBorglin1960" class="citation journal cs1">Borglin, N. E. (1960). "Clinical Evaluation of the Progestational Effect of Allylestrenol". <i>European Journal of Endocrinology</i>. <b>35</b> (4 Suppl): NP–S15. doi:<a href="javascript:if(confirm('https://doi.org/10.1530%2Facta.0.XXXVS0NP  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530%2Facta.0.XXXVS0NP'" tppabs="https://doi.org/10.1530%2Facta.0.XXXVS0NP" class="external text external">10.1530/acta.0.XXXVS0NP</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0804-4643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0804-4643'" tppabs="https://www.worldcat.org/issn/0804-4643" class="external text external">0804-4643</a>.</cite></span></li><li id="cite_note-pmid13699366-15"> <span id="mw-reference-text-cite_note-pmid13699366-15" class="mw-reference-text"><cite id="CITEREFField-RichardsSnaith1961" class="citation journal cs1">Field-Richards S, Snaith L (January 1961). "Allylestrenol: a new oral progestogen". <i>Lancet</i>. <b>1</b> (7169): 134–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fs0140-6736%2861%2991310-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fs0140-6736%2861%2991310-1'" tppabs="https://doi.org/10.1016%2Fs0140-6736%2861%2991310-1" class="external text external">10.1016/s0140-6736(61)91310-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13699366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13699366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13699366" class="external text external">13699366</a>.</cite></span></li><li id="cite_note-Madjerekde_Visser1960-16"> <span id="mw-reference-text-cite_note-Madjerekde_Visser1960-16" class="mw-reference-text"><cite id="CITEREFMadjerekde_Visservan_der_ViesOverbeek1960" class="citation journal cs1">Madjerek, Z.; de Visser, J.; van der Vies, J.; Overbeek, G. A. (1960). "Allylestrenol, a Pregnancy Maintaining Oral Gestagen". <i>European Journal of Endocrinology</i>. <b>XXXV</b> (I): 8–19. doi:<a href="javascript:if(confirm('https://doi.org/10.1530%2Facta.0.XXXV0008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1530%2Facta.0.XXXV0008'" tppabs="https://doi.org/10.1530%2Facta.0.XXXV0008" class="external text external">10.1530/acta.0.XXXV0008</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0804-4643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0804-4643'" tppabs="https://www.worldcat.org/issn/0804-4643" class="external text external">0804-4643</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13765069  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13765069'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13765069" class="external text external">13765069</a>.</cite></span></li><li id="cite_note-pmid18395441-17"> <span id="mw-reference-text-cite_note-pmid18395441-17" class="mw-reference-text"><cite id="CITEREFMcRobbHandelsmanKazlauskasWilkinson2008" class="citation journal cs1">McRobb L, Handelsman DJ, Kazlauskas R, Wilkinson S, McLeod MD, Heather AK (May 2008). "Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay". <i>The Journal of Steroid Biochemistry and Molecular Biology</i>. <b>110</b> (1–2): 39–47. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.jsbmb.2007.10.008  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.jsbmb.2007.10.008'" tppabs="https://doi.org/10.1016%2Fj.jsbmb.2007.10.008" class="external text external">10.1016/j.jsbmb.2007.10.008</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18395441  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18395441'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18395441" class="external text external">18395441</a>.</cite></span></li><li id="cite_note-Zeelen1990-18"> <span id="mw-reference-text-cite_note-Zeelen1990-18" class="mw-reference-text"><cite id="CITEREFF._J._Zeelen1990" class="citation book cs1">F. J. Zeelen (1990). <a href="javascript:if(confirm('https://books.google.com/books?id=px9tAAAAMAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=px9tAAAAMAAJ'" tppabs="https://books.google.com/books?id=px9tAAAAMAAJ" class="external text external"><i>Medicinal chemistry of steroids</i></a>. Elsevier Science Limited. pp.<span>&nbsp;</span>108–109. ISBN<span>&nbsp;</span><bdi>978-0-444-88727-6</bdi>. <q>Other examples are allylestrenol (42), a pro-drug converted to the 3-keto analogue (43), which is used in the treatment of threatened abortion [78,79] and altrenogest (44), used in sows and mares to suppress ovulation and estrus behaviour [80]. [...] Progestins with a 17a-allyl side chain: (42) allylestrenol, (43), (44) altrenogest.</q></cite></span></li><li id="cite_note-Publishing2013-19"> <span id="mw-reference-text-cite_note-Publishing2013-19" class="mw-reference-text"><cite id="CITEREFWilliam_Andrew_Publishing2013" class="citation book cs1">William Andrew Publishing (22 October 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA170  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA170'" tppabs="https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA170" class="external text external"><i>Pharmaceutical Manufacturing Encyclopedia, 3rd Edition</i></a>. Elsevier. pp.<span>&nbsp;</span>170–. ISBN<span>&nbsp;</span><bdi>978-0-8155-1856-3</bdi>.</cite></span></li><li id="cite_note-Field-RichardsSnaith1961-20"> <span id="mw-reference-text-cite_note-Field-RichardsSnaith1961-20" class="mw-reference-text"><cite class="citation journal cs1">Field-Richards S, Snaith L (January 1961). "Allylestrenol: a new oral progestogen". <i>Lancet</i>. <b>1</b> (7169): 134–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0140-6736%2861%2991310-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0140-6736%2861%2991310-1'" tppabs="https://doi.org/10.1016%2FS0140-6736%2861%2991310-1" class="external text external">10.1016/S0140-6736(61)91310-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/13699366  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/13699366'" tppabs="https://pubmed.ncbi.nlm.nih.gov/13699366" class="external text external">13699366</a>.</cite></span></li><li id="cite_note-SimpsonWeiner1997-21"> <span id="mw-reference-text-cite_note-SimpsonWeiner1997-21" class="mw-reference-text"><cite id="CITEREFJ._A._SimpsonE._S._C._Weiner1997" class="citation book cs1">J. A. Simpson; E. S. C. Weiner (1997). <a href="javascript:if(confirm('https://books.google.com/books?id=gUGcAQAAQBAJ&pg=PA36  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=gUGcAQAAQBAJ&pg=PA36'" tppabs="https://books.google.com/books?id=gUGcAQAAQBAJ&pg=PA36" class="external text external"><i>Oxford English Dictionary Additions Series</i></a>. Clarendon Press. pp.<span>&nbsp;</span>36–. ISBN<span>&nbsp;</span><bdi>978-0-19-860027-5</bdi>. <q>1961 Lancet 21 Jan. 135/1 Allylestrenol ('Gestanin', Organon)..seems to be completely free from androgenic activity. 1962 Med. Jrnl. Austral. 8 Sept. 375/2 Each tablet of the combined hormone preparation, 'Premenquil', contains 5 mg. of allyloestrenol. [...]</q></cite></span></li><li id="cite_note-Juta1962-22"> <span id="mw-reference-text-cite_note-Juta1962-22" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=QORDAQAAIAAJ  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=QORDAQAAIAAJ'" tppabs="https://books.google.com/books?id=QORDAQAAIAAJ" class="external text external"><i>Medical Proceedings: A South African Journal for the Advancement of Medical Science</i></a>. Juta and Company. 1962. <q>Just released in South Africa is Gestanin, Organon Laboratories' new safe oral progestogen. Gestanin is allylestrenol, one of a new group of steroids synthesized by Organon.</q></cite></span></li><li id="cite_note-Micromedex-23"> <span id="mw-reference-text-cite_note-Micromedex-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.micromedexsolutions.com/micromedex2/librarian/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.micromedexsolutions.com/micromedex2/librarian/'" tppabs="http://www.micromedexsolutions.com/micromedex2/librarian/" class="external text external">"Micromedex Products: Please Login"</a>.</cite></span></li><li id="cite_note-Drugs.com-24"> <span id="mw-reference-text-cite_note-Drugs.com-24" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/allylestrenol.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/allylestrenol.html'" tppabs="https://www.drugs.com/international/allylestrenol.html" class="external text external">"Allylestrenol"</a>.</cite></span></li><li id="cite_note-IndexNominum2000-25"> <span id="mw-reference-text-cite_note-IndexNominum2000-25" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA29  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA29'" tppabs="https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA29" class="external text external"><i>Index Nominum 2000: International Drug Directory</i></a>. Taylor &amp; Francis. January 2000. pp.<span>&nbsp;</span>29–. ISBN<span>&nbsp;</span><bdi>978-3-88763-075-1</bdi>.</cite></span></li><li id="cite_note-pmid3609436-26"> <span id="mw-reference-text-cite_note-pmid3609436-26" class="mw-reference-text"><cite id="CITEREFBirkenfeldNavotEzraRon1987" class="citation journal cs1">Birkenfeld A, Navot D, Ezra Y, Ron A, Schenker JG (July 1987). "The effect of estradiol valerate and allylestrenol on endometrial transformation in hypergonadotropic hypogonadic women". <i>European Journal of Obstetrics, Gynecology, and Reproductive Biology</i>. <b>25</b> (3): 221–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0028-2243%2887%2990102-X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0028-2243%2887%2990102-X'" tppabs="https://doi.org/10.1016%2F0028-2243%2887%2990102-X" class="external text external">10.1016/0028-2243(87)90102-X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/3609436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/3609436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/3609436" class="external text external">3609436</a>.</cite></span></li><li id="cite_note-pmid1473164-27"> <span id="mw-reference-text-cite_note-pmid1473164-27" class="mw-reference-text"><cite id="CITEREFBartákRozprávkaBlovský1992" class="citation journal cs1">Barták A, Rozprávka M, Blovský J (October 1992). "[Lynestrenol and allylestrenol in the therapy of postmenopausal hot flushes]". <i>Ceskoslovenska Gynekologie</i> (in Czech). <b>57</b> (8): 408–13. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1473164  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1473164'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1473164" class="external text external">1473164</a>.</cite></span></li><li id="cite_note-pmid6203385-28"> <span id="mw-reference-text-cite_note-pmid6203385-28" class="mw-reference-text"><cite id="CITEREFYamanakaKosakuMakinoShida1983" class="citation journal cs1">Yamanaka H, Kosaku N, Makino T, Shida K (September 1983). "[Fundamental and clinical study of the anti-prostatic effect of allylestrenol]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>29</b> (9): 1133–45. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6203385  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6203385'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6203385" class="external text external">6203385</a>.</cite></span></li><li id="cite_note-pmid2425610-29"> <span id="mw-reference-text-cite_note-pmid2425610-29" class="mw-reference-text"><cite id="CITEREFTajimaAsoUshiyamaHata1986" class="citation journal cs1">Tajima A, Aso Y, Ushiyama T, Hata M, Kambayashi T, Ohmi Y, Masuda H, Nakahara M, Kitagawa M, Suzuki A (March 1986). "[Clinical effect of allylestrenol on benign prostatic hypertrophy]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>32</b> (3): 477–85. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2425610  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2425610'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2425610" class="external text external">2425610</a>.</cite></span></li><li id="cite_note-pmid2425611-30"> <span id="mw-reference-text-cite_note-pmid2425611-30" class="mw-reference-text"><cite id="CITEREFKohriKuritaIguchiKataoka1986" class="citation journal cs1">Kohri K, Kurita T, Iguchi M, Kataoka K (March 1986). "[Clinical effects of allylestrenol on prostatic hypertrophy]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>32</b> (3): 486–92. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2425611  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2425611'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2425611" class="external text external">2425611</a>.</cite></span></li><li id="cite_note-pmid2426932-31"> <span id="mw-reference-text-cite_note-pmid2426932-31" class="mw-reference-text"><cite id="CITEREFShidaKoyanagiKawakuraNishida1986" class="citation journal cs1">Shida K, Koyanagi T, Kawakura K, Nishida T, Kumamoto Y, Orikasa S, Sato S, Takeda M, Yamanaka H, Shimazaki J (April 1986). "[Clinical effects of allylestrenol on benign prostatic hypertrophy by double-blind method]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>32</b> (4): 625–48. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2426932  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2426932'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2426932" class="external text external">2426932</a>.</cite></span></li><li id="cite_note-pmid2426933-32"> <span id="mw-reference-text-cite_note-pmid2426933-32" class="mw-reference-text"><cite id="CITEREFOhyamaTanifujiHaraguchiFujii1986" class="citation journal cs1">Ohyama M, Tanifuji T, Haraguchi C, Fujii N, Higaki Y, Yoshida H, Imamura K (April 1986). "[Clinical study of allylestrenol (Org AL-25) on patients with prostatic hypertrophy--transrectal ultrasonography and urodynamic examination]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>32</b> (4): 649–59. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2426933  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2426933'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2426933" class="external text external">2426933</a>.</cite></span></li><li id="cite_note-pmid2435122-33"> <span id="mw-reference-text-cite_note-pmid2435122-33" class="mw-reference-text"><cite id="CITEREFKatayamaUmedaKazama1986" class="citation journal cs1">Katayama T, Umeda K, Kazama T (November 1986). "[Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>32</b> (11): 1584–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/2435122  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/2435122'" tppabs="https://pubmed.ncbi.nlm.nih.gov/2435122" class="external text external">2435122</a>.</cite></span></li><li id="cite_note-pmid1693037-34"> <span id="mw-reference-text-cite_note-pmid1693037-34" class="mw-reference-text"><cite id="CITEREFKumamotoYamaguchiSatoSuzuki1990" class="citation journal cs1">Kumamoto Y, Yamaguchi Y, Sato Y, Suzuki R, Tanda H, Kato S, Mori K, Matsumoto H, Maki A, Kadono M (February 1990). "[Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate Part I: Nocturnal penile tumescence monitoring]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>36</b> (2): 213–26. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1693037  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1693037'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1693037" class="external text external">1693037</a>.</cite></span></li><li id="cite_note-pmid1693038-35"> <span id="mw-reference-text-cite_note-pmid1693038-35" class="mw-reference-text"><cite class="citation journal cs1">Kumamoto Y, Yamaguchi Y, Sato Y, Suzuki R, Tanda H, Kato S, Mori K, Matsumoto H, Maki A, Kadono M (February 1990). <a href="javascript:if(confirm('https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/116823/1/36_213.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/116823/1/36_213.pdf'" tppabs="https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/116823/1/36_213.pdf" class="external text external">"<span>[</span>Effects of anti-androgens on sexual function. Double-blind comparative studies on allylestrenol and chlormadinone acetate. Part II: Self-assessment questionnaire method<span>]</span>"</a> <span class="cs1-format">(PDF)</span>. <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>36</b> (2): 227–44. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1693038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1693038'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1693038" class="external text external">1693038</a>.</cite></span></li><li id="cite_note-pmid1384295-36"> <span id="mw-reference-text-cite_note-pmid1384295-36" class="mw-reference-text"><cite id="CITEREFTsujiAriyoshiNakamuraMichinaga1992" class="citation journal cs1">Tsuji Y, Ariyoshi A, Nakamura H, Michinaga S, Tomita Y, Ohmori A, Tahara H, Yamashita Y, Fujisawa Y, Kajiwara I (August 1992). "[Antiandrogen therapy of benign prostatic hypertrophy: clinical effects of allylestrenol evaluated by transrectal ultrasonographic measurement]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>38</b> (8): 961–6. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1384295  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1384295'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1384295" class="external text external">1384295</a>.</cite></span></li><li id="cite_note-pmid7689782-37"> <span id="mw-reference-text-cite_note-pmid7689782-37" class="mw-reference-text"><cite id="CITEREFFukuokaIshibashiShibaTuchiya1993" class="citation journal cs1">Fukuoka H, Ishibashi Y, Shiba T, Tuchiya F, Sakanishi S (July 1993). "[Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>39</b> (7): 679–83. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7689782  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7689782'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7689782" class="external text external">7689782</a>.</cite></span></li><li id="cite_note-pmid7513937-38"> <span id="mw-reference-text-cite_note-pmid7513937-38" class="mw-reference-text"><cite id="CITEREFIguchiIkeuchiKaiYoshida1994" class="citation journal cs1">Iguchi H, Ikeuchi T, Kai Y, Yoshida H (March 1994). "[Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>40</b> (3): 215–9. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7513937  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7513937'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7513937" class="external text external">7513937</a>.</cite></span></li><li id="cite_note-pmid7541089-39"> <span id="mw-reference-text-cite_note-pmid7541089-39" class="mw-reference-text"><cite id="CITEREFHoritaKumamotoSatohSuzuki1995" class="citation journal cs1">Horita H, Kumamoto Y, Satoh Y, Suzuki N, Wada H, Shibuya A, Adachi H, Kurohata T, Tsukamoto T (May 1995). "[The preventive effect of indeloxazine hydrochloride to the sexual dysfunction caused by anti-androgenergic agent (allylestrenol)]". <i>Nihon Hinyokika Gakkai Zasshi. The Japanese Journal of Urology</i> (in Japanese). <b>86</b> (5): 1044–50. doi:<a href="javascript:if(confirm('https://doi.org/10.5980%2Fjpnjurol1989.86.1044  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.5980%2Fjpnjurol1989.86.1044'" tppabs="https://doi.org/10.5980%2Fjpnjurol1989.86.1044" class="external text external">10.5980/jpnjurol1989.86.1044</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7541089  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7541089'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7541089" class="external text external">7541089</a>.</cite></span></li><li id="cite_note-pmid9781436-40"> <span id="mw-reference-text-cite_note-pmid9781436-40" class="mw-reference-text"><cite id="CITEREFNoguchiHaradaMasudaTakeda1998" class="citation journal cs1">Noguchi K, Harada M, Masuda M, Takeda M, Kinoshita Y, Fukushima S, Miyai K, Fukuoka H, Hosaka M (September 1998). "Clinical significance of interruption of therapy with allylestrenol in patients with benign prostatic hypertrophy". <i>International Journal of Urology</i>. <b>5</b> (5): 466–70. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1442-2042.1998.tb00389.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1442-2042.1998.tb00389.x'" tppabs="https://doi.org/10.1111%2Fj.1442-2042.1998.tb00389.x" class="external text external">10.1111/j.1442-2042.1998.tb00389.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9781436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9781436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9781436" class="external text external">9781436</a>.</cite></span></li><li id="cite_note-pmid11107528-41"> <span id="mw-reference-text-cite_note-pmid11107528-41" class="mw-reference-text"><cite id="CITEREFNoguchiUemuraTakedaSekiguchi2000" class="citation journal cs1">Noguchi K, Uemura H, Takeda M, Sekiguchi Y, Ogawa K, Hosaka M (September 2000). "[Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>46</b> (9): 605–7. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11107528  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11107528'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11107528" class="external text external">11107528</a>.</cite></span></li><li id="cite_note-pmid12094708-42"> <span id="mw-reference-text-cite_note-pmid12094708-42" class="mw-reference-text"><cite id="CITEREFNoguchiTakedaHosakaKubota2002" class="citation journal cs1">Noguchi K, Takeda M, Hosaka M, Kubota Y (May 2002). "[Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH]". <i>Hinyokika Kiyo. Acta Urologica Japonica</i> (in Japanese). <b>48</b> (5): 269–73. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12094708  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12094708'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12094708" class="external text external">12094708</a>.</cite></span></li><li id="cite_note-pmid16910584-43"> <span id="mw-reference-text-cite_note-pmid16910584-43" class="mw-reference-text"><cite id="CITEREFNoguchiSuzukiTeranishiKondo2006" class="citation journal cs1">Noguchi K, Suzuki K, Teranishi J, Kondo K, Kishida T, Saito K, Uemura H, Kubota Y (July 2006). "Recovery of serum prostate specific antigen value after interruption of antiandrogen therapy with allylestrenol for benign prostatic hyperplasia". <i>Hinyokika Kiyo. Acta Urologica Japonica</i>. <b>52</b> (7): 527–30. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16910584  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16910584'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16910584" class="external text external">16910584</a>.</cite></span></li><li id="cite_note-pmid6281750-44"> <span id="mw-reference-text-cite_note-pmid6281750-44" class="mw-reference-text"><cite id="CITEREFTakeuchi1981" class="citation journal cs1">Takeuchi H (1981). "The therapeutic effect of concurrent administration of 5-fluorouracil and allylestrenol or hexestrol in small doses on prostatic carcinoma". <i>The Prostate. Supplement</i>. <b>1</b>: 111–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fpros.2990020518  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fpros.2990020518'" tppabs="https://doi.org/10.1002%2Fpros.2990020518" class="external text external">10.1002/pros.2990020518</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6281750  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6281750'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6281750" class="external text external">6281750</a>.</cite></span></li><li id="cite_note-pmid5057420-45"> <span id="mw-reference-text-cite_note-pmid5057420-45" class="mw-reference-text"><cite id="CITEREFRiquelme_MorenoMontiel_LópezBravo_GuerraEscobar_Cauz1972" class="citation journal cs1">Riquelme Moreno E, Montiel López P, Bravo Guerra R, Escobar Cauz G (July 1972). "[Control of 5 cases of idiopathic precocious puberty with allylestrenol]". <i>Ginecologia y Obstetricia de Mexico</i> (in Spanish). <b>32</b> (189): 99–108. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5057420  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5057420'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5057420" class="external text external">5057420</a>.</cite></span></li><li id="cite_note-Tripathi2013-46"> <span id="mw-reference-text-cite_note-Tripathi2013-46" class="mw-reference-text"><cite id="CITEREFKD_Tripathi2013" class="citation book cs1">KD Tripathi (30 September 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=FfG8AQAAQBAJ&pg=PA318  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=FfG8AQAAQBAJ&pg=PA318'" tppabs="https://books.google.com/books?id=FfG8AQAAQBAJ&pg=PA318" class="external text external"><i>Essentials of Medical Pharmacology</i></a>. JP Medical Ltd. pp.<span>&nbsp;</span>318–. ISBN<span>&nbsp;</span><bdi>978-93-5025-937-5</bdi>.</cite></span></li><li id="cite_note-SatoskarRege1973-47"> <span id="mw-reference-text-cite_note-SatoskarRege1973-47" class="mw-reference-text"><cite id="CITEREFR._S._SatoskarS._D._Bhandarkar_&amp;nirmala_N._Rege1973" class="citation book cs1">R. S. Satoskar; S. D. Bhandarkar &amp;nirmala N. Rege (1973). <a href="javascript:if(confirm('https://books.google.com/books?id=7d493VOD4P8C&pg=PA941  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=7d493VOD4P8C&pg=PA941'" tppabs="https://books.google.com/books?id=7d493VOD4P8C&pg=PA941" class="external text external"><i>Pharmacology and Pharmacotherapeutics</i></a>. Popular Prakashan. pp.<span>&nbsp;</span>941–. ISBN<span>&nbsp;</span><bdi>978-81-7991-527-1</bdi>.</cite></span></li><li id="cite_note-pmid7065053-48"> <span id="mw-reference-text-cite_note-pmid7065053-48" class="mw-reference-text"><cite id="CITEREFRozenbaum1982" class="citation journal cs1">Rozenbaum H (March 1982). "Relationships between chemical structure and biological properties of progestogens". <i>American Journal of Obstetrics and Gynecology</i>. <b>142</b> (6 Pt 2): 719–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0002-9378%2816%2932477-2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0002-9378%2816%2932477-2'" tppabs="https://doi.org/10.1016%2FS0002-9378%2816%2932477-2" class="external text external">10.1016/S0002-9378(16)32477-2</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7065053  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7065053'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7065053" class="external text external">7065053</a>.</cite></span></li><li id="cite_note-pmid22078182-49"> <span id="mw-reference-text-cite_note-pmid22078182-49" class="mw-reference-text"><cite id="CITEREFEndrikatGerlingerRichardRosenbaum2011" class="citation journal cs1">Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B (December 2011). "Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide". <i>Contraception</i>. <b>84</b> (6): 549–57. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.contraception.2011.04.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.contraception.2011.04.009'" tppabs="https://doi.org/10.1016%2Fj.contraception.2011.04.009" class="external text external">10.1016/j.contraception.2011.04.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22078182  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22078182'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22078182" class="external text external">22078182</a>.</cite></span></li><li id="cite_note-Pincus2013-50"> <span id="mw-reference-text-cite_note-Pincus2013-50" class="mw-reference-text"><cite id="CITEREFGregory_Pincus2013" class="citation book cs1">Gregory Pincus (3 September 2013). <a href="javascript:if(confirm('https://books.google.com/books?id=ehQlBQAAQBAJ&pg=PA222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=ehQlBQAAQBAJ&pg=PA222'" tppabs="https://books.google.com/books?id=ehQlBQAAQBAJ&pg=PA222" class="external text external"><i>The Control of Fertility</i></a>. Elsevier. pp.<span>&nbsp;</span>222–. ISBN<span>&nbsp;</span><bdi>978-1-4832-7088-3</bdi>.</cite></span></li><li id="cite_note-LeidenbergerStrowitzki2009-51"> <span id="mw-reference-text-cite_note-LeidenbergerStrowitzki2009-51" class="mw-reference-text"><cite id="CITEREFFreimut_A._LeidenbergerThomas_StrowitzkiOlaf_Ortmann2009" class="citation book cs1">Freimut A. Leidenberger; Thomas Strowitzki; Olaf Ortmann (29 August 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=bqokBAAAQBAJ&pg=PA225  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=bqokBAAAQBAJ&pg=PA225'" tppabs="https://books.google.com/books?id=bqokBAAAQBAJ&pg=PA225" class="external text external"><i>Klinische Endokrinologie für Frauenärzte</i></a>. Springer-Verlag. pp.<span>&nbsp;</span>225–. ISBN<span>&nbsp;</span><bdi>978-3-540-89760-6</bdi>.</cite></span></li><li id="cite_note-pmid9268084-52"> <span id="mw-reference-text-cite_note-pmid9268084-52" class="mw-reference-text"><cite id="CITEREFYasudaFujinoShirajiNambu1997" class="citation journal cs1">Yasuda N, Fujino K, Shiraji T, Nambu F, Kondo K (July 1997). <a href="javascript:if(confirm('https://doi.org/10.1254/jjp.74.243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1254/jjp.74.243'" tppabs="https://doi.org/10.1254/jjp.74.243" class="external text external">"Effects of steroid 5alpha-reductase inhibitor ONO-9302 and anti-androgen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats"</a>. <i>Japanese Journal of Pharmacology</i>. <b>74</b> (3): 243–52. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1254%2Fjjp.74.243  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1254%2Fjjp.74.243'" tppabs="https://doi.org/10.1254%2Fjjp.74.243" class="external text external">10.1254/jjp.74.243</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9268084  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9268084'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9268084" class="external text external">9268084</a>.</cite></span></li><li id="cite_note-pmid7000222-53"> <span id="mw-reference-text-cite_note-pmid7000222-53" class="mw-reference-text"><cite id="CITEREFJacobiAltweinKurthBasting1980" class="citation journal cs1">Jacobi GH, Altwein JE, Kurth KH, Basting R, Hohenfellner R (June 1980). "Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial". <i>British Journal of Urology</i>. <b>52</b> (3): 208–15. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1464-410X.1980.tb02961.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1464-410X.1980.tb02961.x'" tppabs="https://doi.org/10.1111%2Fj.1464-410X.1980.tb02961.x" class="external text external">10.1111/j.1464-410X.1980.tb02961.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7000222  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7000222'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7000222" class="external text external">7000222</a>.</cite></span></li><li id="cite_note-pmid6237116-54"> <span id="mw-reference-text-cite_note-pmid6237116-54" class="mw-reference-text"><cite id="CITEREFKnuthHanoNieschlag1984" class="citation journal cs1">Knuth UA, Hano R, Nieschlag E (November 1984). "Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>59</b> (5): 963–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1210%2Fjcem-59-5-963  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1210%2Fjcem-59-5-963'" tppabs="https://doi.org/10.1210%2Fjcem-59-5-963" class="external text external">10.1210/jcem-59-5-963</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/6237116  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/6237116'" tppabs="https://pubmed.ncbi.nlm.nih.gov/6237116" class="external text external">6237116</a>.</cite></span></li><li id="cite_note-pmid694436-55"> <span id="mw-reference-text-cite_note-pmid694436-55" class="mw-reference-text"><cite id="CITEREFSanderNissen-MeyerAakvaag1978" class="citation journal cs1">Sander S, Nissen-Meyer R, Aakvaag A (1978). "On gestagen treatment of advanced prostatic carcinoma". <i>Scandinavian Journal of Urology and Nephrology</i>. <b>12</b> (2): 119–21. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F00365597809179977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F00365597809179977'" tppabs="https://doi.org/10.3109%2F00365597809179977" class="external text external">10.3109/00365597809179977</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/694436  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/694436'" tppabs="https://pubmed.ncbi.nlm.nih.gov/694436" class="external text external">694436</a>.</cite></span></li><li id="cite_note-Elks2014-56"> <span id="mw-reference-text-cite_note-Elks2014-56" class="mw-reference-text"><cite id="CITEREFJ._Elks2014" class="citation book cs1">J. Elks (14 November 2014). <a href="javascript:if(confirm('https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA31  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA31'" tppabs="https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA31" class="external text external"><i>The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies</i></a>. Springer. pp.<span>&nbsp;</span>31–. ISBN<span>&nbsp;</span><bdi>978-1-4757-2085-3</bdi>.</cite></span></li><li id="cite_note-MVJain2017-57"> <span id="mw-reference-text-cite_note-MVJain2017-57" class="mw-reference-text"><cite id="CITEREFAnita_MVSandhya_JainNeerja_Goel2017" class="citation book cs1">Anita MV; Sandhya Jain; Neerja Goel (31 December 2017). <a href="javascript:if(confirm('https://books.google.com/books?id=VrpEDwAAQBAJ&pg=PA10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=VrpEDwAAQBAJ&pg=PA10'" tppabs="https://books.google.com/books?id=VrpEDwAAQBAJ&pg=PA10" class="external text external"><i>Use of Progestogens in Clinical Practice of Obstetrics and Gynecology</i></a>. JP Medical Ltd. pp.<span>&nbsp;</span>10–. ISBN<span>&nbsp;</span><bdi>978-93-5270-218-3</bdi>.</cite></span></li><li id="cite_note-Aronson2009-58"> <span id="mw-reference-text-cite_note-Aronson2009-58" class="mw-reference-text"><cite id="CITEREFJeffrey_K._Aronson2009" class="citation book cs1">Jeffrey K. Aronson (21 February 2009). <a href="javascript:if(confirm('https://books.google.com/books?id=BWMeSwVwfTkC&pg=PA289  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=BWMeSwVwfTkC&pg=PA289'" tppabs="https://books.google.com/books?id=BWMeSwVwfTkC&pg=PA289" class="external text external"><i>Meyler's Side Effects of Endocrine and Metabolic Drugs</i></a>. Elsevier. pp.<span>&nbsp;</span>289–. ISBN<span>&nbsp;</span><bdi>978-0-08-093292-7</bdi>.</cite></span></li><li id="cite_note-GunnetDixon2000-59"> <span id="mw-reference-text-cite_note-GunnetDixon2000-59" class="mw-reference-text"><cite id="CITEREFGunnetDixon2000" class="citation book cs1">Gunnet JW, Dixon LA (2000). "Hormones, Sex Hormones". <i>Kirk-Othmer Encyclopedia of Chemical Technology</i>. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F0471238961.19052407211414.a01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F0471238961.19052407211414.a01'" tppabs="https://doi.org/10.1002%2F0471238961.19052407211414.a01" class="external text external">10.1002/0471238961.19052407211414.a01</a>. ISBN<span>&nbsp;</span><bdi>978-0471238966</bdi>.</cite></span></li><li id="cite_note-Springer2013-60"> <span id="mw-reference-text-cite_note-Springer2013-60" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://books.google.com/books?id=t8GpBgAAQBAJ&pg=PA16  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=t8GpBgAAQBAJ&pg=PA16'" tppabs="https://books.google.com/books?id=t8GpBgAAQBAJ&pg=PA16" class="external text external"><i>Die Gestagene</i></a>. Springer-Verlag. 27 November 2013. p.<span>&nbsp;</span>16. ISBN<span>&nbsp;</span><bdi>978-3-642-99941-3</bdi>.</cite></span></li><li id="cite_note-DeWinterSiegman1959-61"> <span id="mw-reference-text-cite_note-DeWinterSiegman1959-61" class="mw-reference-text"><cite id="CITEREFDe_WinterSiegmanSzpilfogel1959" class="citation journal cs1">De Winter MS, Siegman CM, Szpilfogel SA (1959). "17-alkylated-3-deoxo-19-nor-testosterone". <i>Chem. Ind.</i>: 905.</cite></span></li><li id="cite_note-MortonHall2012-62"> <span id="mw-reference-text-cite_note-MortonHall2012-62" class="mw-reference-text"><cite id="CITEREFMortonHall2012" class="citation book cs1">Morton IK, Hall JM (6 December 2012). <a href="javascript:if(confirm('https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA11  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA11'" tppabs="https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA11" class="external text external"><i>Concise Dictionary of Pharmacological Agents: Properties and Synonyms</i></a>. Springer Science &amp; Business Media. pp.<span>&nbsp;</span>11–. ISBN<span>&nbsp;</span><bdi>978-94-011-4439-1</bdi>.</cite></span></li></ol></div></div>

<div role="navigation" class="navbox" aria-labelledby="Progestogens_and_antiprogestogens" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progestogens_and_antiprogestogens" style="font-size:114%;margin:0 4em">Progestogens and antiprogestogens</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Progestogens<br>(and progestins)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="PR_agonists" scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> Progesterone</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> <a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Hydroxyprogesterone (and closely related) derivatives:</i> <i>17α-Hydroxylated:</i> Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone acetophenide (dihydroxyprogesterone acetophenide)</li>
<li>Anagestone acetate</li>
<li>Chlormadinone acetate</li>
<li>Chlormethenmadinone acetate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone acetate</li>
<li>Flugestone acetate (flurogestone acetate)</li>
<li>Flumedroxone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate</li>
<li>Hydroxyprogesterone heptanoate</li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a><sup>#</sup></li>
<li>Megestrol acetate</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone acetate</li>
<li>Osaterone acetate</li>
<li>Pentagestrone acetate</li>
<li>Proligestone; <i>17α-Methylated:</i> Medrogestone; <i>Others:</i> Haloprogesterone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> <i>17α-Hydroxylated:</i> Gestonorone caproate (gestronol hexanoate)</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>Segesterone acetate (nestorone, elcometrine); <i>17α-Methylated:</i> Demegestone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> <i>Estranes:</i> <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li>Dimethisterone</li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li></ul>

<ul><li><i>19-Nortestosterone derivatives:</i> <i>Estranes:</i> <a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Dienogest</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li>Lynestrenol</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a><sup>#</sup></li>
<li>Norethisterone acetate</li>
<li>Norethisterone enanthate</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li>Norgestrienone</li>
<li>Normethandrone (methylestrenolone)</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol acetate</li>
<li>Tibolone; <i>Gonanes:</i> <a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a><sup>#</sup></li>
<li>Norelgestromin</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li></ul>

<ul><li><i>Spirolactone derivatives:</i> <a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li></ul>

<ul><li><i>Others:</i> Anabolic–androgenic steroids (e.g., <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">nandrolone</a> and esters, trenbolone and esters, <a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">ethylestrenol</a>, norethandrolone, others)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;">Antiprogestogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>SPRMs</abbr></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Telapristone<sup>§</sup></li>
<li>Ulipristal acetate</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:8em;;text-align:center;"><abbr>PR</abbr> antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Aglepristone</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0px;background:#DDDDFF;"><div style="padding:0em 0.25em"><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div>
<dl><dt>See also</dt>
<dd>Progesterone receptor modulators</dd>
<dd>Androgens and antiandrogens</dd>
<dd>Estrogens and antiestrogens</dd>
<dd>List of progestogens</dd></dl></div></td></tr></tbody></table></div><span>
</span>
<div role="navigation" class="navbox" aria-labelledby="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Drugs_used_in_benign_prostatic_hyperplasia_(G04C)" style="font-size:114%;margin:0 4em">Drugs used in benign prostatic hyperplasia (G04C)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">5α-Reductase inhibitors</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Dutasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Dutasteride" title="Dutasteride">Dutasteride</a></li>
<li>Epristeride</li>
<li><a href="Finasteride.htm" tppabs="https://ptable.com/wiki/compounds/A/Finasteride" title="Finasteride">Finasteride</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Alpha-1 blockers</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Alfuzosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alfuzosin" title="Alfuzosin">Alfuzosin</a></li>
<li><a href="Doxazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxazosin" title="Doxazosin">Doxazosin</a></li>
<li>Silodosin</li>
<li><a href="Tamsulosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tamsulosin" title="Tamsulosin">Tamsulosin</a></li>
<li><a href="Terazosin.htm" tppabs="https://ptable.com/wiki/compounds/A/Terazosin" title="Terazosin">Terazosin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Steroidal antiandrogens</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Delmadinone acetate</li>
<li>Gestonorone caproate</li>
<li>Osaterone acetate</li>
<li>Oxendolone</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Herbal products</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Pygeum africanum</i></li>
<li><i>Saw palmetto extract</i></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Mepartricin</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Progesterone_receptor_modulators" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Progesterone_receptor_modulators" style="font-size:114%;margin:0 4em">Progesterone receptor modulators</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>PR</abbr></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Progesterone derivatives:</i> 3β-Dihydroprogesterone</li>
<li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>6α-Methylprogesterone</li>
<li>9α-Bromo-11-ketoprogesterone</li>
<li>11-Dehydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycorticosterone</a></li>
<li>16α-Hydroxyprogesterone</li>
<li><span class="new">17α-Methyl-11-deoxycorticosterone acetate</span></li>
<li>20α-Dihydroprogesterone</li>
<li>20β-Dihydroprogesterone</li>
<li>Dimepregnen</li>
<li><a href="Diosgenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Diosgenin" title="Diosgenin">Diosgenin</a></li>
<li>P1-185</li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li>
<li>Progesterone 3-acetyl enol ether</li>
<li>Quingestrone</li></ul>

<ul><li><i>Retroprogesterone derivatives:</i> 20α-Dihydrodydrogesterone</li>
<li>20α-Dihydrotrengestone</li>
<li>DU-41164</li>
<li>DU-41165</li>
<li><a href="Dydrogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Dydrogesterone" title="Dydrogesterone">Dydrogesterone</a></li>
<li>Retroprogesterone</li>
<li>Ro 6-3129</li>
<li>Trengestone</li></ul>

<ul><li><i>17α-Substituted progesterone derivatives:</i> 6α-Methyl-17α-bromoprogesterone</li>
<li>15β-Hydroxycyproterone acetate</li>
<li>16-Methylene-17α-hydroxyprogesterone acetate</li>
<li>17α-Bromoprogesterone</li>
<li>17α-Hydroxyprogesterone (hydroxyprogesterone)</li>
<li>17α-Methylprogesterone</li>
<li>Acetomepregenol (mepregenol diacetate)</li>
<li>Algestone</li>
<li>Algestone acetonide</li>
<li>Algestone acetophenide</li>
<li>Anagestone</li>
<li>Anagestone acetate</li>
<li><span class="new">Bromethenmadinone</span></li>
<li>Bromethenmadinone acetate</li>
<li>Butagest (buterol)</li>
<li>Chlormadinone</li>
<li>Chlormadinone acetate</li>
<li>Chlormadinone caproate</li>
<li><span class="new">Chlormethenmadinone</span></li>
<li>Chlormethenmadinone acetate</li>
<li>Cismadinone</li>
<li>Cismadinone acetate</li>
<li>Clogestone</li>
<li>Clogestone acetate</li>
<li>Clomegestone</li>
<li>Clomegestone acetate</li>
<li>Cymegesolate</li>
<li>Cyproterone acetate</li>
<li>Delmadinone</li>
<li>Delmadinone acetate</li>
<li>Edogestrone</li>
<li>Flugestone</li>
<li>Flugestone acetate</li>
<li><a href="Fluorometholone.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorometholone" title="Fluorometholone">Fluorometholone</a></li>
<li>Fluorometholone acetate</li>
<li>Flumedroxone</li>
<li>Flumedroxone acetate</li>
<li>Fluoromedroxyprogesterone acetate</li>
<li>Gestaclone</li>
<li>Haloprogesterone</li>
<li>Hydromadinone</li>
<li>Hydromadinone acetate</li>
<li>Hydroxyprogesterone acetate</li>
<li>Hydroxyprogesterone caproate (hydroxyprogesterone hexanoate)</li>
<li>Hydroxyprogesterone heptanoate (hydroxyprogesterone enanthate)</li>
<li>Hydroxyprogesterone heptanoate benzilic acid hydrazone</li>
<li>Mecigestone (pentarane B)</li>
<li>Medrogestone</li>
<li><a href="Medroxyprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone" title="Medroxyprogesterone">Medroxyprogesterone</a></li>
<li><a href="Medroxyprogesterone_acetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Medroxyprogesterone_acetate" title="Medroxyprogesterone acetate">Medroxyprogesterone acetate</a></li>
<li>Medroxyprogesterone caproate</li>
<li><a href="Megestrol.htm" tppabs="https://ptable.com/wiki/compounds/A/Megestrol" title="Megestrol">Megestrol</a></li>
<li>Megestrol acetate</li>
<li>Megestrol caproate</li>
<li>Melengestrol</li>
<li>Melengestrol acetate</li>
<li>Methenmadinone</li>
<li>Methenmadinone acetate</li>
<li>Methenmadinone caproate</li>
<li>Mometasone</li>
<li><a href="Mometasone_furoate.htm" tppabs="https://ptable.com/wiki/compounds/A/Mometasone_furoate" title="Mometasone furoate" class="mw-redirect">Mometasone furoate</a></li>
<li>Osaterone</li>
<li>Osaterone acetate</li>
<li>Pentagestrone</li>
<li>Pentagestrone acetate</li>
<li>Pentarane A</li>
<li>Proligestone</li></ul>

<ul><li><i>19-Norprogesterone derivatives:</i> 17α-Methyl-19-norprogesterone</li>
<li>18-Methylsegesterone acetate</li>
<li>19-Norprogesterone</li>
<li>Amadinone</li>
<li>Amadinone acetate</li>
<li>Demegestone</li>
<li><span class="new">Fluoro ethyl norprogesterone</span></li>
<li><span class="new">Fluoro furanyl norprogesterone</span></li>
<li>Gestadienol</li>
<li>Gestadienol acetate</li>
<li>Gestonorone acetate (gestronol acetate)</li>
<li>Gestonorone caproate (gestronol hexanoate)</li>
<li>Gestronol (gestonorone)</li>
<li>Nomegestrol</li>
<li>Nomegestrol acetate</li>
<li>Norgestomet</li>
<li>ORG-2058</li>
<li>Oxogestone</li>
<li>Oxogestone phenpropionate (xinogestone)</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Promegestone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Promegestone'" tppabs="https://ptable.com/wiki/compounds/A/Promegestone" title="Promegestone">Promegestone</a></li>
<li>Segesterone</li>
<li>Segesterone acetate (nestorone)</li>
<li>Trimegestone</li></ul>

<ul><li><i>Testosterone derivatives:</i> Progestins: 6,6-Difluoronorethisterone</li>
<li>6,6-Difluoronorethisterone acetate</li>
<li>17α-Allyl-19-nortestosterone</li>
<li><a href="Allylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Allylestrenol" title="Allylestrenol">Allylestrenol</a></li>
<li>Altrenogest</li>
<li>Chloroethynylnorgestrel</li>
<li>Cingestol</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Danazol  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Danazol'" tppabs="https://ptable.com/wiki/compounds/A/Danazol" title="Danazol">Danazol</a></li>
<li><a href="Desogestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Desogestrel" title="Desogestrel">Desogestrel</a></li>
<li>Dienogest</li>
<li>Ethinylandrostenediol
<ul><li>Ethandrostate</li></ul></li>
<li><a href="Ethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethisterone" title="Ethisterone">Ethisterone</a></li>
<li>Ethynerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Etonogestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Etonogestrel'" tppabs="https://ptable.com/wiki/compounds/A/Etonogestrel" title="Etonogestrel">Etonogestrel</a></li>
<li>Etynodiol</li>
<li><a href="Etynodiol_diacetate.htm" tppabs="https://ptable.com/wiki/compounds/A/Etynodiol_diacetate" title="Etynodiol diacetate">Etynodiol diacetate</a></li>
<li><a href="Gestodene.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestodene" title="Gestodene">Gestodene</a></li>
<li><a href="Gestrinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Gestrinone" title="Gestrinone">Gestrinone</a></li>
<li><a href="Levonorgestrel.htm" tppabs="https://ptable.com/wiki/compounds/A/Levonorgestrel" title="Levonorgestrel">Levonorgestrel</a></li>
<li>Levonorgestrel esters (e.g., levonorgestrel butanoate)</li>
<li>Lynestrenol</li>
<li>Lynestrenol phenylpropionate</li>
<li>Metynodiol</li>
<li>Metynodiol diacetate</li>
<li>Norelgestromin</li>
<li><a href="Norethisterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Norethisterone" title="Norethisterone">Norethisterone (norethindrone)</a></li>
<li>Norethisterone esters (e.g., norethisterone acetate, norethisterone enanthate)</li>
<li>Noretynodrel</li>
<li>Norgesterone</li>
<li><a href="Norgestimate.htm" tppabs="https://ptable.com/wiki/compounds/A/Norgestimate" title="Norgestimate">Norgestimate</a></li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Norgestrel  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Norgestrel'" tppabs="https://ptable.com/wiki/compounds/A/Norgestrel" title="Norgestrel">Norgestrel</a></li>
<li>Norgestrienone</li>
<li>Norvinisterone</li>
<li>Oxendolone</li>
<li>Quingestanol</li>
<li>Quingestanol acetate</li>
<li>Tibolone</li>
<li>Tigestol</li>
<li>Tosagestin; Anabolic–androgenic steroids: 11β-Methyl-19-nortestosterone</li>
<li>11β-Methyl-19-nortestosterone dodecylcarbonate</li>
<li>19-Nor-5-androstenediol</li>
<li>19-Nor-5-androstenedione</li>
<li>19-Nordehydroepiandrosterone</li>
<li>Bolandiol</li>
<li>Bolandiol dipropionate</li>
<li>Bolandione</li>
<li>Dimethisterone</li>
<li>Dienedione</li>
<li>Dienolone</li>
<li>Dimethandrolone</li>
<li>Dimethandrolone buciclate</li>
<li>Dimethandrolone dodecylcarbonate</li>
<li>Dimethandrolone undecanoate</li>
<li>Dimethyldienolone</li>
<li>Dimethyltrienolone</li>
<li>Ethyldienolone</li>
<li><a href="Ethylestrenol.htm" tppabs="https://ptable.com/wiki/compounds/A/Ethylestrenol" title="Ethylestrenol">Ethylestrenol (ethylnandrol)</a></li>
<li>Methyldienolone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Metribolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Metribolone'" tppabs="https://ptable.com/wiki/compounds/A/Metribolone" title="Metribolone">Metribolone (R-1881)</a></li>
<li>Methoxydienone (methoxygonadiene)</li>
<li>Mibolerone</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Nandrolone  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Nandrolone'" tppabs="https://ptable.com/wiki/compounds/A/Nandrolone" title="Nandrolone">Nandrolone</a></li>
<li>Nandrolone esters (e.g., nandrolone decanoate, nandrolone phenylpropionate)</li>
<li>Norethandrolone</li>
<li>Normethandrone (methylestrenolone, normethandrolone, normethisterone)</li>
<li>RU-2309</li>
<li>Tetrahydrogestrinone</li>
<li>Trenbolone (trienolone)</li>
<li>Trenbolone esters (e.g., trenbolone acetate, trenbolone enanthate)</li>
<li>Trendione</li>
<li>Trestolone</li>
<li>Trestolone acetate</li></ul>

<ul><li><i>Spirolactone derivatives:</i> Canrenoic acid</li>
<li>Canrenone</li>
<li><a href="Drospirenone.htm" tppabs="https://ptable.com/wiki/compounds/A/Drospirenone" title="Drospirenone">Drospirenone</a></li>
<li>Mespirenone</li>
<li>Potassium canrenoate</li>
<li>Prorenone</li>
<li>SC-5233 (spirolactone)</li>
<li>SC-8109</li>
<li><a href="Spironolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Spironolactone" title="Spironolactone">Spironolactone</a></li>
<li>Spirorenone</li></ul>

<ul><li><i>Nonsteroidal:</i> 3,8-Dihydrodiligustilide</li>
<li>LG-2527</li>
<li><span class="new">LG-100128</span></li>
<li>Riligustilide</li>
<li><span class="new">RWJ-26819</span></li>
<li><span class="new">RWJ-49853</span></li>
<li><span class="new">RWJ-60130</span></li>
<li>Tanaproget</li>
<li>ZM-182345</li></ul>

<ul><li><i>Unknown:</i> ORG-47241</li>
<li>ORG-201745</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Mixed<br>(<abbr>SPRMs</abbr>)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Dihydroethisterone</li>
<li>5α-Dihydrolevonorgestrel</li>
<li>5α-Dihydronorethisterone</li>
<li>Asoprisnil</li>
<li>Asoprisnil ecamate</li>
<li>Guggulsterone</li>
<li><span class="new">J1042</span></li>
<li><span class="new">LG-120838</span></li>
<li>Metapristone (RU-42633)</li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone (RU-486)</a></li>
<li><span class="new">ORF-9371</span></li>
<li>ORF-9326</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RMI-12936</span></li>
<li>Telapristone</li>
<li>Ulipristal acetate</li>
<li>Vilaprisan</li>
<li><span class="new">ZK-137316</span></li></ul>

<ul><li><i>Nonsteroidal:</i> <a href="Apigenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Apigenin" title="Apigenin">Apigenin</a></li>
<li><a href="Kaempferol.htm" tppabs="https://ptable.com/wiki/compounds/A/Kaempferol" title="Kaempferol">Kaempferol</a></li>
<li><span class="new">LG-120920</span></li>
<li><a href="Naringenin.htm" tppabs="https://ptable.com/wiki/compounds/A/Naringenin" title="Naringenin">Naringenin</a></li>
<li><span class="new">PRA-910</span></li>
<li><a href="Syringic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Syringic_acid" title="Syringic acid">Syringic acid</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Steroidal:</i> Aglepristone</li>
<li>Lilopristone</li>
<li>Lonaprisan</li>
<li>Onapristone</li>
<li><span class="new">ORG-31710</span></li>
<li><span class="new">ORG-31806</span></li>
<li><span class="new">ORG-33628</span></li>
<li><span class="new">RTI 3021–022</span></li>
<li>Toripristone</li>
<li>Zanoterone</li></ul>

<ul><li><i>Nonsteroidal:</i> Darolutamide</li>
<li><span class="new">LG-001447</span></li>
<li><span class="new">LG-100127</span></li>
<li><span class="new">LG-100128</span></li>
<li><span class="new">LG-120830</span></li>
<li><span class="new">LG-121046</span></li>
<li><a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">Valproic acid</a></li>
<li><span class="new">ZM-150271</span></li>
<li><span class="new">ZM-172406</span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align:center;"><abbr>mPR</abbr><br>(<abbr>PAQR</abbr>)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Agonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="5α-Dihydroprogesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/5%CE%B1-Dihydroprogesterone" title="5α-Dihydroprogesterone">5α-Dihydroprogesterone</a></li>
<li>5β-Dihydroprogesterone</li>
<li><a href="11-Deoxycorticosterone.htm" tppabs="https://ptable.com/wiki/compounds/A/11-Deoxycorticosterone" title="11-Deoxycorticosterone">11-Deoxycortisone (21-hydroxyprogesterone)</a></li>
<li>11-Deoxycortisol (17α,21-dihydroxyprogesterone)</li>
<li>17α-Hydroxyprogesterone</li>
<li><a href="Allopregnanolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Allopregnanolone" title="Allopregnanolone">Allopregnanolone</a></li>
<li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li>
<li><a href="Pregnenolone.htm" tppabs="https://ptable.com/wiki/compounds/A/Pregnenolone" title="Pregnenolone">Pregnenolone</a></li>
<li><a href="Progesterone.htm" tppabs="https://ptable.com/wiki/compounds/A/Progesterone" title="Progesterone">Progesterone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:6em;;text-align:center">Antagonists</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Mifepristone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mifepristone" title="Mifepristone">Mifepristone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<dl><dt>See also</dt>
<dd>Receptor/signaling modulators</dd>
<dd>Progestogens and antiprogestogens</dd>
<dd>Androgen receptor modulators</dd>
<dd>Estrogen receptor modulators</dd>
<dd>List of progestogens</dd></dl>
</div></td></tr></tbody></table></div><span>
</span>








<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-06-21" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Allylestrenol&oldid=963670006  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Allylestrenol&oldid=963670006'" tppabs="https://en.wikipedia.org/wiki/?title=Allylestrenol&oldid=963670006">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>